BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35113161)

  • 1. SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games.
    Akashi H; Shimada S; Tamura T; Chinda E; Kokudo N
    JAMA; 2022 Mar; 327(10):978-980. PubMed ID: 35113161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games.
    Urashima M; Takao H; Sakano T; Takeshita K; Yoshida M; Nakazawa Y; Kawai M; Murayama Y
    Intern Med; 2022 Dec; 61(24):3659-3666. PubMed ID: 36198605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020.
    Yashio T; Murayama A; Kami M; Ozaki A; Tanimoto T; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 44():102205. PubMed ID: 34785374
    [No Abstract]   [Full Text] [Related]  

  • 4. Contributions of the Tokyo 2020 Infectious Diseases Control Centre in curbing SARS-CoV-2 spread during the Olympic and Paralympic Games.
    Shimada S; Ikenoue C; Iwashita Y; Miyamoto T
    Br J Sports Med; 2023 Jan; 57(1):6-7. PubMed ID: 36113974
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of SARS-CoV-2 Load in Wastewater With Reported COVID-19 Cases in the Tokyo 2020 Olympic and Paralympic Village From July to September 2021.
    Kitajima M; Murakami M; Kadoya SS; Ando H; Kuroita T; Katayama H; Imoto S
    JAMA Netw Open; 2022 Aug; 5(8):e2226822. PubMed ID: 35994292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    McCloskey B; Saito T; Shimada S; Ikenoue C; Endericks T; Mullen L; Mota P; Kumar CK; Laxminarayan R; Budgett R; Heymann D; Zumla A
    Lancet; 2024 Feb; 403(10425):493-502. PubMed ID: 38244561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 wastewater surveillance implemented in the Tokyo 2020 Olympic and Paralympic Village.
    Kitajima M; Murakami M; Iwamoto R; Katayama H; Imoto S
    J Travel Med; 2022 May; 29(3):. PubMed ID: 35134222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisource surveillance conducted by the Tokyo Metropolitan Government during the Tokyo 2020 Olympic and Paralympic Games.
    Sugishita Y; Somura Y; Abe N; Murai Y; Koike Y; Suzuki E; Yanagibayashi M; Kayebeta A; Yoshida A
    Western Pac Surveill Response J; 2023; 14(3):1-10. PubMed ID: 37955030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Team USA COVID-19 Prevalence at Tokyo 2020 Summer Olympic and Paralympic Games.
    Adams WM; Anderson T; Finnoff JT
    Curr Sports Med Rep; 2023 Feb; 22(2):49-51. PubMed ID: 36757122
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 infection risk assessment and management at the Tokyo 2020 Olympic and Paralympic Games: A scoping review.
    Murakami M; Fujii K; Naito W; Kamo M; Kitajima M; Yasutaka T; Imoto S
    J Infect Public Health; 2024 Apr; 17 Suppl 1():18-26. PubMed ID: 37032255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games.
    Kasamatsu A; Ota M; Shimada T; Fukusumi M; Yamagishi T; Samuel A; Nakashita M; Ukai T; Kurosawa K; Urakawa M; Takahashi K; Tsukada K; Futami A; Inoue H; Omori S; Kobayashi M; Komiya H; Shimada T; Tabata S; Yahata Y; Kamiya H; Yoshimatsu F; Sunagawa T; Saito T
    Western Pac Surveill Response J; 2021; 12(4):1-7. PubMed ID: 35251745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not all fun and games: Potential incidence of SARS-CoV-2 infections during the Tokyo 2020 Olympic Games.
    Linton NM; Jung SM; Nishiura H
    Math Biosci Eng; 2021 Nov; 18(6):9685-9696. PubMed ID: 34814363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global warming and the Summer Olympic and Paralympic games: a perspective from the Tokyo 2020 Games.
    Yamasaki L; Nomura S
    Environ Health Prev Med; 2022; 27():7. PubMed ID: 35288491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021.
    Shimizu K; Gilmour S; Mase H; Le PM; Teshima A; Sakamoto H; Nomura S
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33807268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Did the Tokyo Olympic Games enhance the transmission of COVID-19? An interpretation with machine learning.
    Hirata A; Kodera S; Diao Y; Rashed EA
    Comput Biol Med; 2022 Jul; 146():105548. PubMed ID: 35537221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy services at the Tokyo 2020 Olympic and Paralympic Games: perspectives of the pharmacy workforce.
    Kasashi K; Sato A; Stuart M; Thomas T; Kim SH; Jang DM; File H; Suzuki S; Rhie SJ
    Br J Sports Med; 2023 Jan; 57(1):40-45. PubMed ID: 36198477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games.
    Tsuzuki S; Asai Y; Ibuka Y; Nakaya T; Ohmagari N; Hens N; Beutels P
    J Glob Health; 2022 Dec; 12():05047. PubMed ID: 36462208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 pandemic on athletes with disabilities preparing for the Paralympic Games in Tokyo.
    Urbański P; Szeliga Ł; Tasiemski T
    BMC Res Notes; 2021 Jun; 14(1):233. PubMed ID: 34127078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Risk Assessment for the Tokyo Olympic Games.
    Zhu W; Feng J; Li C; Wang H; Zhong Y; Zhou L; Zhang X; Zhang T
    Front Public Health; 2021; 9():730611. PubMed ID: 34760863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.